Inspire Medical Systems Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $898.7M+12.0% YoYTTM through 30 Jun 2026
Net Income $135M+152.4% YoYTTM through 30 Jun 2026
Free Cash Flow $117.1MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 86.5% |
| EBITDA Margin | 7.9% |
| Operating Margin | -0.5% |
| Net Margin | 15.0% |
Returns
16.5%ROE
14.4%ROA
16.5%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio6.34x
Net Debt-$283.8Mnet cash position
Cash & Equivalents$127.8M
Quality Metrics
Altman Z-Score13.94
Piotroski F-Score8 / 9
FCF Margin13.0%
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $912M
Diluted EPS$4.53TTMFY2025: $4.89
Dividend
No dividend
Capital Allocation
R&D Spend$99.7M
Capex Intensity4.4%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.